In the abscence of any real information we must resort to reading faces and body language of the CEO?
Oteen and Nusel, you live in Israel. Is there any buzz around the company? Do you know anyone who works there that can give a sense of the activity level?
Still waiting for real information:
1. Why is Israel taking so long to approve since the May 1st FDA approval? Is anyone in Israel paying for the medication?
2. Brazil and Australia?
3. Are we really selling our med 25% cheaper? Has any drug actually been shipped?
4. Has Pfizer found any untreated patients to market to? India? China?
5. Fabry IND. Wasn't it supposed to be in Q2?
6. When are earnings reported? Will Elelyso be included?
7. No new updates on biodefense drug in quite some time.
8. Any other sources of revenue possible? Talking to any other pharm companies about licensing the plant platform to produce other proteins?
9. Any progress on winning back the ability to market in Europe? How big is the market in Europe?
More questions than answers.
I hope this is worth the wait.